Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature Reviews …, 2021 - nature.com
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …
被引用次数：36 相关文章

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature reviews …, 2021 - europepmc.org
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe, SO John… - Nature Reviews …, 2021 - search.proquest.com
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature Reviews …, 2021 - go.gale.com
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …
[HTML] nih.gov

[HTML][HTML] Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature reviews …, 2021 - ncbi.nlm.nih.gov
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature Reviews …, 2021 - escholarship.org
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …
[PDF] researchgate.net

[PDF][PDF] Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes, D Vesprini… - Nature - researchgate.net
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.

A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes… - Nature reviews …, 2021 - europepmc.org
Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …